Merck & Co., Inc. (LON:0QAH)
London · Delayed Price · Currency is GBP · Price in USD 112.01
+0.93 (0.84%)
Jan 9, 2026, 5:04 PM GMT
Merck & Co. Market Cap
Merck & Co. has a market cap or net worth of 204.64 billion as of January 9, 2026. Its market cap has increased by 1.88% in one year.
Market Cap
204.64B
Enterprise Value
221.96B
Revenue
47.79B
Ranking
n/a
PE Ratio
14.45
Stock Price
112.01
Market Cap Chart
Since January 2, 1968, Merck & Co.'s market cap has increased from 3.01B to 204.64B, an increase of 6,708.37%. That is a compound annual growth rate of 7.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 204.64B | 5.42% |
| Dec 31, 2025 | 194.11B | -3.43% |
| Dec 31, 2024 | 201.01B | -7.32% |
| Dec 29, 2023 | 216.89B | -7.10% |
| Dec 30, 2022 | 233.47B | 63.30% |
| Dec 31, 2021 | 142.97B | -5.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 219.86B |
| GSK plc | 75.67B |
| Haleon | 32.73B |
| Smith & Nephew | 10.69B |
| Convatec Group | 4.80B |
| Hikma Pharmaceuticals | 3.49B |
| HUTCHMED (China) | 1.87B |
| Genus | 1.72B |